Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Nov;40(11):2646–2647. doi: 10.1128/aac.40.11.2646

In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.

J A Frean 1, L Arntzen 1, T Capper 1, A Bryskier 1, K P Klugman 1
PMCID: PMC163592  PMID: 8913481

Abstract

A limited repertoire of antimicrobial agents is currently in use for the treatment of plague. We investigated the in vitro activities of some newer antimicrobial agents against Yersinia pestis. Among the injectable agents tested, cefotaxime was the most active, and among the oral agents, both levofloxacin and ofloxacin were highly active, with MICs at which 90% of isolates are inhibited of < 0.03 microgram/ml. the susceptibilities to the ketolide RU004 and the penem faropenem warrant attention. The enhanced activities of quinolones against Y. pestis suggest that these agents should be further investigated for the treatment of human plague in the future.

Full Text

The Full Text of this article is available as a PDF (166.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barreto A., Aragon M., Epstein P. R. Bubonic plague outbreak in Mozambique, 1994. Lancet. 1995 Apr 15;345(8955):983–984. doi: 10.1016/s0140-6736(95)90730-0. [DOI] [PubMed] [Google Scholar]
  2. Bonacorsi S. P., Scavizzi M. R., Guiyoule A., Amouroux J. H., Carniel E. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother. 1994 Mar;38(3):481–486. doi: 10.1128/aac.38.3.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butler T. Yersinia infections: centennial of the discovery of the plague bacillus. Clin Infect Dis. 1994 Oct;19(4):655–663. doi: 10.1093/clinids/19.4.655. [DOI] [PubMed] [Google Scholar]
  4. Dennis D. T. Plague in India. BMJ. 1994 Oct 8;309(6959):893–894. doi: 10.1136/bmj.309.6959.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hamilton-Miller J. M. Calculating MIC50. J Antimicrob Chemother. 1991 Jun;27(6):863–864. doi: 10.1093/jac/27.6.863. [DOI] [PubMed] [Google Scholar]
  6. Hoogkamp-Korstanje J. A. The possible role of quinolones in yersiniosis. Drugs. 1987;34 (Suppl 1):134–138. doi: 10.2165/00003495-198700341-00029. [DOI] [PubMed] [Google Scholar]
  7. Lemaitre B. C., Mazigh D. A., Scavizzi M. R. Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection. Antimicrob Agents Chemother. 1991 Sep;35(9):1785–1790. doi: 10.1128/aac.35.9.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MEYER K. F. Modern therapy of plague. J Am Med Assoc. 1950 Nov 18;144(12):982–985. doi: 10.1001/jama.1950.02920120006003. [DOI] [PubMed] [Google Scholar]
  9. Rasoamanana B., Coulanges P., Michel P., Rasolofonirina N. Sensibilité de Yersinia pestis aux antibiotiques: 277 souches isolées à Madagascar entre 1926 et 1989. Arch Inst Pasteur Madagascar. 1989;56(1):37–53. [PubMed] [Google Scholar]
  10. Russell P., Eley S. M., Bell D. L., Manchee R. J., Titball R. W. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. J Antimicrob Chemother. 1996 Apr;37(4):769–774. doi: 10.1093/jac/37.4.769. [DOI] [PubMed] [Google Scholar]
  11. Williams J. E., Arntzen L., Tyndal G. L., Isaäcson M. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982. Bull World Health Organ. 1986;64(5):745–752. [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES